TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $319 | -99.4% | 21,224 | +74.1% | 0.03% | +750.0% |
| Q2 2022 | $52,000 | -73.5% | 12,191 | -40.7% | 0.00% | -73.3% |
| Q1 2022 | $196,000 | -22.2% | 20,565 | +216.7% | 0.02% | -37.5% |
| Q2 2021 | $252,000 | -72.1% | 6,493 | -62.5% | 0.02% | -75.3% |
| Q4 2020 | $902,000 | +342.2% | 17,330 | +65.4% | 0.10% | +304.2% |
| Q2 2020 | $204,000 | -43.5% | 10,477 | -67.8% | 0.02% | -31.4% |
| Q4 2019 | $361,000 | +423.2% | 32,551 | +165.2% | 0.04% | +600.0% |
| Q3 2019 | $69,000 | -67.3% | 12,273 | -76.2% | 0.01% | -54.5% |
| Q4 2018 | $211,000 | +263.8% | 51,570 | +399.5% | 0.01% | +175.0% |
| Q3 2018 | $58,000 | -88.8% | 10,325 | -71.8% | 0.00% | -85.7% |
| Q1 2018 | $520,000 | +37.6% | 36,592 | -20.5% | 0.03% | +40.0% |
| Q4 2017 | $378,000 | +58.8% | 46,055 | +129.0% | 0.02% | +66.7% |
| Q3 2017 | $238,000 | – | 20,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |